Background: The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and
effective for sudden cardiac death prevention. However, patients in previous S-ICD studies …

Aims To report 5-year outcomes of EFFORTLESS registry patients with early generation
subcutaneous implantable cardioverter-defibrillator (S-ICD) devices. Methods and results …

Background Most inappropriate shocks from the subcutaneous implantable cardioverter-
defibrillator (S-ICD) are caused by cardiac oversensing. A novel sensing methodology …

The ICD is an important part of the treatment and prevention of sudden cardiac death in
many high-risk populations. Traditional transvenous ICDs (TV-ICDs) are associated with …

In recent years an extension of devices longevity has been obtained for implantable
cardioverter-defibrillators (ICDs), including ICDs for cardiac resynchronization therapy (CRT …

Objectives This study evaluated spontaneous arrhythmias and clinical outcomes in the S-
ICD System PAS (Subcutaneous Implantable Cardioverter-Defibrillator Post Approval Study) …

Aims Patients with cardiomyopathies and channelopathies are usually younger and have a
predominantly arrhythmia-related prognosis; they have nearly normal life expectancy thanks …

Aims In subcutaneous implantable cardioverter defibrillator (S-ICD) recipients, the
UNTOUCHED study demonstrated a very low inappropriate shock rate on programming a …

Aims Comparison of outcomes between subcutaneous and transvenous implantable
cardioverter-defibrillator (S-ICD and TV-ICD) therapy is hampered by varying patient …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is an accepted
alternative to transvenous (TV) ICD to provide defibrillation therapy to treat life-threatening …